UniProt ID | BAP1_HUMAN | |
---|---|---|
UniProt AC | Q92560 | |
Protein Name | Ubiquitin carboxyl-terminal hydrolase BAP1 | |
Gene Name | BAP1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 729 | |
Subcellular Localization | Cytoplasm . Nucleus . Mainly nuclear. Binds to chromatin. Localizes to the cytoplasm when monoubiquitinated by the E2/E3 hybrid ubiquitin-protein ligase UBE2O (PubMed:24703950). | |
Protein Description | Deubiquitinating enzyme that plays a key role in chromatin by mediating deubiquitination of histone H2A and HCFC1. Catalytic component of the PR-DUB complex, a complex that specifically mediates deubiquitination of histone H2A monoubiquitinated at 'Lys-119' (H2AK119ub1). Does not deubiquitinate monoubiquitinated histone H2B. Acts as a regulator of cell growth by mediating deubiquitination of HCFC1 N-terminal and C-terminal chains, with some specificity toward 'Lys-48'-linked polyubiquitin chains compared to 'Lys-63'-linked polyubiquitin chains. Deubiquitination of HCFC1 does not lead to increase stability of HCFC1. Interferes with the BRCA1 and BARD1 heterodimer activity by inhibiting their ability to mediate ubiquitination and autoubiquitination. It however does not mediate deubiquitination of BRCA1 and BARD1. Able to mediate autodeubiquitination via intramolecular interactions to couteract monoubiquitination at the nuclear localization signal (NLS), thereby protecting it from cytoplasmic sequestration. [PubMed: 24703950 Acts as a tumor suppressor.] | |
Protein Sequence | MNKGWLELESDPGLFTLLVEDFGVKGVQVEEIYDLQSKCQGPVYGFIFLFKWIEERRSRRKVSTLVDDTSVIDDDIVNNMFFAHQLIPNSCATHALLSVLLNCSSVDLGPTLSRMKDFTKGFSPESKGYAIGNAPELAKAHNSHARPEPRHLPEKQNGLSAVRTMEAFHFVSYVPITGRLFELDGLKVYPIDHGPWGEDEEWTDKARRVIMERIGLATAGEPYHDIRFNLMAVVPDRRIKYEARLHVLKVNRQTVLEALQQLIRVTQPELIQTHKSQESQLPEESKSASNKSPLVLEANRAPAASEGNHTDGAEEAAGSCAQAPSHSPPNKPKLVVKPPGSSLNGVHPNPTPIVQRLPAFLDNHNYAKSPMQEEEDLAAGVGRSRVPVRPPQQYSDDEDDYEDDEEDDVQNTNSALRYKGKGTGKPGALSGSADGQLSVLQPNTINVLAEKLKESQKDLSIPLSIKTSSGAGSPAVAVPTHSQPSPTPSNESTDTASEIGSAFNSPLRSPIRSANPTRPSSPVTSHISKVLFGEDDSLLRVDCIRYNRAVRDLGPVISTGLLHLAEDGVLSPLALTEGGKGSSPSIRPIQGSQGSSSPVEKEVVEATDSREKTGMVRPGEPLSGEKYSPKELLALLKCVEAEIANYEACLKEEVEKRKKFKIDDQRRTHNYDEFICTFISMLAQEGMLANLVEQNISVRRRQGVSIGRLHKQRKPDRRKRSRPYKAKRQ | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
120 | Ubiquitination | SRMKDFTKGFSPESK HHHHHHHCCCCHHHC | 58.93 | - | |
123 | Phosphorylation | KDFTKGFSPESKGYA HHHHCCCCHHHCCCC | 36.10 | 29396449 | |
126 | Phosphorylation | TKGFSPESKGYAIGN HCCCCHHHCCCCCCC | 34.46 | 27251275 | |
127 | Ubiquitination | KGFSPESKGYAIGNA CCCCHHHCCCCCCCH | 55.04 | - | |
139 | Ubiquitination | GNAPELAKAHNSHAR CCHHHHHHHHCCCCC | 63.90 | 21890473 | |
139 | Ubiquitination | GNAPELAKAHNSHAR CCHHHHHHHHCCCCC | 63.90 | 21890473 | |
143 | Phosphorylation | ELAKAHNSHARPEPR HHHHHHCCCCCCCCC | 14.51 | 25554490 | |
155 | Acetylation | EPRHLPEKQNGLSAV CCCCCCCHHCCHHHH | 47.31 | 23749302 | |
155 | Ubiquitination | EPRHLPEKQNGLSAV CCCCCCCHHCCHHHH | 47.31 | - | |
223 | Phosphorylation | LATAGEPYHDIRFNL CCCCCCCCCCCEEEE | 14.07 | 27642862 | |
241 | Phosphorylation | VPDRRIKYEARLHVL CCCCCCHHEEEEEEE | 16.67 | - | |
254 | Phosphorylation | VLKVNRQTVLEALQQ EEECCHHHHHHHHHH | 24.66 | 30622161 | |
273 | Phosphorylation | TQPELIQTHKSQESQ HCHHHHHHCHHHHHC | 25.03 | 29214152 | |
275 | Ubiquitination | PELIQTHKSQESQLP HHHHHHCHHHHHCCC | 58.17 | - | |
276 | Phosphorylation | ELIQTHKSQESQLPE HHHHHCHHHHHCCCH | 31.41 | 25159151 | |
279 | Phosphorylation | QTHKSQESQLPEESK HHCHHHHHCCCHHHH | 29.40 | 28555341 | |
285 | Phosphorylation | ESQLPEESKSASNKS HHCCCHHHHCCCCCC | 30.19 | 26074081 | |
287 | Phosphorylation | QLPEESKSASNKSPL CCCHHHHCCCCCCCE | 46.32 | 23927012 | |
289 | Phosphorylation | PEESKSASNKSPLVL CHHHHCCCCCCCEEE | 52.46 | 30278072 | |
292 | Phosphorylation | SKSASNKSPLVLEAN HHCCCCCCCEEEEEC | 27.93 | 19664994 | |
305 | Phosphorylation | ANRAPAASEGNHTDG ECCCCCHHCCCCCCC | 48.41 | 29970186 | |
310 | Phosphorylation | AASEGNHTDGAEEAA CHHCCCCCCCHHHHC | 39.88 | 29970186 | |
319 | Phosphorylation | GAEEAAGSCAQAPSH CHHHHCHHCCCCCCC | 11.10 | 27794612 | |
325 | Phosphorylation | GSCAQAPSHSPPNKP HHCCCCCCCCCCCCC | 39.34 | 23401153 | |
327 | Phosphorylation | CAQAPSHSPPNKPKL CCCCCCCCCCCCCCE | 46.52 | 25159151 | |
366 | Phosphorylation | AFLDNHNYAKSPMQE HHHHCCCCCCCCCCH | 14.09 | 27642862 | |
369 | Phosphorylation | DNHNYAKSPMQEEED HCCCCCCCCCCHHHH | 19.89 | 25159151 | |
371 | Sulfoxidation | HNYAKSPMQEEEDLA CCCCCCCCCHHHHHH | 11.48 | 21406390 | |
384 | Phosphorylation | LAAGVGRSRVPVRPP HHCCCCCCCCCCCCC | 31.53 | 27794612 | |
394 | Phosphorylation | PVRPPQQYSDDEDDY CCCCCCCCCCCCCCC | 14.60 | 21955146 | |
395 | Phosphorylation | VRPPQQYSDDEDDYE CCCCCCCCCCCCCCC | 33.96 | 25159151 | |
401 | Phosphorylation | YSDDEDDYEDDEEDD CCCCCCCCCCCCCCC | 33.31 | 21955146 | |
412 | Phosphorylation | EEDDVQNTNSALRYK CCCCCCCHHHHHHHC | 17.29 | 26074081 | |
414 | Phosphorylation | DDVQNTNSALRYKGK CCCCCHHHHHHHCCC | 27.00 | 26074081 | |
425 | Acetylation | YKGKGTGKPGALSGS HCCCCCCCCCCCCCC | 39.87 | 26051181 | |
451 | Acetylation | TINVLAEKLKESQKD HHHHHHHHHHHHHCC | 60.29 | 26051181 | |
455 | Phosphorylation | LAEKLKESQKDLSIP HHHHHHHHHCCCCCC | 40.73 | 29083192 | |
460 | Phosphorylation | KESQKDLSIPLSIKT HHHHCCCCCCEEEEC | 32.09 | 30266825 | |
464 | Phosphorylation | KDLSIPLSIKTSSGA CCCCCCEEEECCCCC | 19.38 | 26329039 | |
467 | Phosphorylation | SIPLSIKTSSGAGSP CCCEEEECCCCCCCC | 26.84 | 23312004 | |
468 | Phosphorylation | IPLSIKTSSGAGSPA CCEEEECCCCCCCCC | 23.05 | 23312004 | |
469 | Phosphorylation | PLSIKTSSGAGSPAV CEEEECCCCCCCCCE | 37.58 | 23312004 | |
473 | Phosphorylation | KTSSGAGSPAVAVPT ECCCCCCCCCEEECC | 14.78 | 23312004 | |
480 | Phosphorylation | SPAVAVPTHSQPSPT CCCEEECCCCCCCCC | 27.79 | 26074081 | |
482 | Phosphorylation | AVAVPTHSQPSPTPS CEEECCCCCCCCCCC | 46.38 | 26074081 | |
485 | Phosphorylation | VPTHSQPSPTPSNES ECCCCCCCCCCCCCC | 33.49 | 26074081 | |
487 | Phosphorylation | THSQPSPTPSNESTD CCCCCCCCCCCCCCC | 43.62 | 26074081 | |
489 | Phosphorylation | SQPSPTPSNESTDTA CCCCCCCCCCCCCCH | 56.56 | 26074081 | |
492 | Phosphorylation | SPTPSNESTDTASEI CCCCCCCCCCCHHHH | 35.51 | 26074081 | |
493 | Phosphorylation | PTPSNESTDTASEIG CCCCCCCCCCHHHHH | 31.06 | 26074081 | |
495 | Phosphorylation | PSNESTDTASEIGSA CCCCCCCCHHHHHHH | 31.97 | 30576142 | |
497 | Phosphorylation | NESTDTASEIGSAFN CCCCCCHHHHHHHHC | 31.66 | 23312004 | |
501 | Phosphorylation | DTASEIGSAFNSPLR CCHHHHHHHHCCCCC | 35.03 | 23312004 | |
505 | Phosphorylation | EIGSAFNSPLRSPIR HHHHHHCCCCCCCCC | 20.89 | 30576142 | |
509 | Phosphorylation | AFNSPLRSPIRSANP HHCCCCCCCCCCCCC | 32.15 | 27251275 | |
513 | Phosphorylation | PLRSPIRSANPTRPS CCCCCCCCCCCCCCC | 32.87 | 23927012 | |
517 | Phosphorylation | PIRSANPTRPSSPVT CCCCCCCCCCCCCCC | 55.83 | 23401153 | |
520 | Phosphorylation | SANPTRPSSPVTSHI CCCCCCCCCCCCHHH | 43.94 | 23401153 | |
521 | Phosphorylation | ANPTRPSSPVTSHIS CCCCCCCCCCCHHHH | 26.52 | 22167270 | |
524 | Phosphorylation | TRPSSPVTSHISKVL CCCCCCCCHHHHHHH | 20.26 | 22167270 | |
525 | Phosphorylation | RPSSPVTSHISKVLF CCCCCCCHHHHHHHH | 21.03 | 23927012 | |
528 | Phosphorylation | SPVTSHISKVLFGED CCCCHHHHHHHHCCC | 15.99 | 23927012 | |
537 | Phosphorylation | VLFGEDDSLLRVDCI HHHCCCCCCEEHHHH | 41.44 | 23917254 | |
571 | Phosphorylation | LAEDGVLSPLALTEG HHCCCCCCCEEECCC | 18.56 | - | |
582 | Phosphorylation | LTEGGKGSSPSIRPI ECCCCCCCCCCCCCC | 42.43 | 30266825 | |
583 | Phosphorylation | TEGGKGSSPSIRPIQ CCCCCCCCCCCCCCC | 31.19 | 25159151 | |
585 | Phosphorylation | GGKGSSPSIRPIQGS CCCCCCCCCCCCCCC | 32.93 | 30266825 | |
592 | Phosphorylation | SIRPIQGSQGSSSPV CCCCCCCCCCCCCCC | 18.26 | 17525332 | |
595 | Phosphorylation | PIQGSQGSSSPVEKE CCCCCCCCCCCCCHH | 21.72 | 25159151 | |
596 | Phosphorylation | IQGSQGSSSPVEKEV CCCCCCCCCCCCHHH | 45.55 | 29255136 | |
597 | Phosphorylation | QGSQGSSSPVEKEVV CCCCCCCCCCCHHHH | 34.36 | 29255136 | |
609 | Phosphorylation | EVVEATDSREKTGMV HHHHCCCCCCCCCCC | 37.67 | 25159151 | |
615 | Sulfoxidation | DSREKTGMVRPGEPL CCCCCCCCCCCCCCC | 2.53 | 21406390 | |
630 | Ubiquitination | SGEKYSPKELLALLK CCCCCCHHHHHHHHH | 55.86 | 21890473 | |
630 | Ubiquitination | SGEKYSPKELLALLK CCCCCCHHHHHHHHH | 55.86 | 21890473 | |
656 | Methylation | CLKEEVEKRKKFKID HHHHHHHHHHCCCCC | 74.76 | - | |
658 | Methylation | KEEVEKRKKFKIDDQ HHHHHHHHCCCCCCC | 73.88 | - | |
659 | Methylation | EEVEKRKKFKIDDQR HHHHHHHCCCCCCCH | 56.79 | - | |
705 | Phosphorylation | VRRRQGVSIGRLHKQ HHHHCCCCHHHHHHC | 26.59 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of BAP1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of BAP1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of BAP1_HUMAN !! |
loading...
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-327; SER-582 ANDSER-597, AND MASS SPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-395, AND MASSSPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-583; SER-592 ANDSER-597, AND MASS SPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-487 AND SER-489, ANDMASS SPECTROMETRY. |